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epatitis E is an important public health 
problem in many developing countries. 
The disease generally affects young 
Adults. The causative agent of Hepatitis E, 
Hepatitis E virus (HEV), is a single-stranded 
positive-sense RNA virus without an envelope 
(1). HEV is generally transmitted by fecal-oral 
route. The genomic RNA of HEV is about 7.5 
kb with three open reading frames (ORFs). 
ORF1 is predicted to encode viral nonstructural 
proteins, ORF2 encodes the putative capsid 
protein, and ORF3 encodes a cytoskeleton-
associated phosphoprotein (2, 3). HEV was 
originally classified as a calicivirus, but recent 
data showed that HEV does not share some 
common important features with caliciviruses. 
It was recently declassified from the 
Caliciviridae family and remains unclassified 
(4). 
Iran is a part of developing Asia with high 
incidence and prevalence of type A hepatitis, 
therefore it is expected to have incidences of 
Hepatitis E. Unfortunately, there has been no 
documented study to explain the statistical 
characteristics of this infection in the general 
population. We studied the level of 
seropositivity of a group of blood donors in a 
cross-sectional study in Kerman during 2007-
2008 (5).  
H 
Among the 400 plasma samples analyzed, a 
total of 31 were found to be positive for anti-
HEV IgG, corresponding to a prevalence rate 
of 7.7%, however, no significant difference 
was observed (P = 0.45).  
No data on type of job activities of the donors 
were available, but it was interested  to know  
whether some of them had occupations 
involved in animal contacts. Another 
possibility is that sanitation may play a more 
prominent role in urban than rural areas. None 
of the positive donors had recently traveled  to 
the endemic regions, but they might  have 
traveled outside Kerman long time ago and  
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Fig. 1:  Frequency distribution of anti HEV 
seropositivity in association with age in 400 men 
blood donors. 
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Age group(years) Urban area     no.pos./no.test.(%) Rural area no.pos./no.test.(%) 
20-30 3/98(3%) 0/37(0%) 
30-40 4/123(3.2%) 3/22(13.6%) 
40-50 9/80(11.8%) 5/15(33.3%) 
50-60 5/23(21.7%) 
been exposed to HEV. Thus, it is not possible 
to conclude that HEV was acquired locally. 
Hepatitis E is observed in young adults in our 
endemic regions while in industrialized 
countries, HEV seems to be more frequent in 
older adults. To characterize this 
epidemiological feature of HEV infection in 
Kerman, the data of four different age groups 
were analyzed: 20-30, 30-40, 40-50 and 50-60 
years old of age (Figure1 and 2). Figure1 
shows the prevalence of anti-HEV positivity in 
different age groups, and the Fig. 2 shows the  
frequency of this distribution. Table 1 also 
shows Age-specific prevalence of hepatitis E 
virus (HEV) IgG antibodies in subjects from  
rural and urban area.   Thus, the probability of 
exposure to HEV seems to increase with age. 
The overall prevalence of anti-HEV antibodies  
among our blood donors was 7.4%, which is 
generally higher than figures reported from 
developed countries (0.4% to 3.9%) (6, 7), and 
lower than those from other countries of the 
Eastern Mediterranean Region (52%).  
The obtained value is higher than those 
obtained in Israel (Jews 2.81% and Arabs 
1.81%) and Ankara, Turkey (3.8%), but less 
than studied values of Iraqis-Kurdish refugees 
(14.8%), blood donors in Saudi Arabia (16.4%)  
and general population in Pakistan (17.5%). 
The ratio was more or less similar to the value 
obtained in a group of healthy blood donors in 
Riyadh (8.37%) (5). 
There are no published study regarding the 
prevalence and incidence of HEV infection in 
Kerman. We studied anti-HEV seropositivity 
in a group of healthy blood donors in Kerman 
and noticed a prevalence of more than 7.4%, 
which correlates with the prevalence of 
endemic areas. 
Our method of screening detected anti HEV 
IgG, which is a routine test to detect HEV 
infection. No significant difference was 
observed in seropositivity between males and 
females. The lowest rate of seropositivity was 
observed in less than 20-30 years, and a peak 
level in the 30-40 years of age followed by a 
decline in the higher ages.  Our data correlates 
to most other studies. 
2/2(100%) 
Total 21/324(6.4%) 10/76(13.1%) 
Table 1: Age-specific prevalence of hepatitis E virus (HEV) IgG antibodies in subjects from rural and 
urban area 
Since the HEV excretion is not usual, 
transmission rate and prevalence of the 
infection is low.  
According to the results of our study we 
conclude that Kerman is an endemic area of 
type E hepatitis and we suggest further 
investigation since there will be higher 
incidence of the infection in general population 
particularly in rural areas. 
Determination of anti-HEV in healthy blood 
donors is not routine now.  The available kits 
to detect anti-HEV IgM have some limitations. 
Although the HEV-specific polymerase chain 
reaction (PCR) test is sensitive and specific, 
screening of the blood using PCR would not be 
cost-effective. In conclusion, seroprevalence of 
the HEV among blood donors in our study in 
Kerman is high, but we cannot recommend 
screening of all blood donors for HEV until 
more data becomes available and further 
knowledge about the mode of transmission of 
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